Stockscreener 앱 받기
8.0001
2.40%
-0.1966
시간 외 거래:
8.12
0.1199
+1.50%
Femto Technologies Inc 주식(BCAN)의 최신 뉴스
ULVAC Launches Technology Center PYEONGTAEK for Next-Gen Semiconductor Manufacturing Equipment in South Korea - JCN Newswire
Introducing the World's First Rugged Rel 17 5G + Wi-Fi 7 Mobile Hotspot: Sonim H700 Debuts at Telstra - JCN Newswire
NEC launches new end to end private 5G solution with Cisco - japancorp.net
EduEdge Introduces Formula-Style Method, Changing English Mastery for Struggling Students - japancorp.net
TOYOTA GAZOO Racing to Exhibit Immersive Content at Super Taikyu Series 2024 Final Fuji - japancorp.net
Fujitsu and Toyota Systems Corporation achieve 50% reduction in core system update time using generative AI - japancorp.net
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award' - japancorp.net
DIFC continues to drive global action in shaping greener economiesAnnounces 2nd edition of the Future Sustainability Forum in Dubai - japancorp.net
Foodrella Tteokbokki Captivates Global Taste Buds - japancorp.net
Valuufy appoints Dr Sachio Semmoto to Chairman of the Board, Signaling a New Era in Sustainability Assessment - japancorp.net
GJK Facility Services Hosts Educational Session With Dr. Chantel Thornton During Breast Cancer Awareness Week - japancorp.net
Femto Technologies Inc. Announces Consolidation of Enhanced Voting Preference Shares - ACN Newswire
HEROWORKS to Participate in TTA 2024, Initiating Comprehensive Expansion into the Singapore Market - JCN Newswire
Canyon Network Secures $6 Million at $60M Valuation for Its Onchain AI Oracle - JCN Newswire
Streamlined DNA Library Preparation Solutions and Guidelines for Robust Quality Control of PCR-free WGS Libraries - SelectScience
Is Sample Integrity Assessment for Long-read Sequencing Technologies Essential? - SelectScience
BYND Cannasoft Enterprises (NASDAQ:BCAN) versus eGain (NASDAQ:EGAN) Critical Review - Defense World
DENSO Announces Changes of Executive Responsibility and Executive Officers - JCN Newswire
GA-ASI Adds NIDV and NATO DIANA to Blue Magic Netherlands Agenda - JCN Newswire
BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) Short Interest Update - Defense World
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.16% - MSN
Mazda to open new R&D office in Azabudai Hills in early summer 2025 - JCN Newswire
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Down to $11.90 - Defense World
Market Insights: FibroGen Inc (FGEN)’s Notable Drop of -1.78, Closing at 0.41 - The Dwinnex
Investing in Fortress Biotech Inc (FBIO) Is Getting More Attractive - Knox Daily
Cantor Fitzgerald Lowers 4D Molecular Therapeutics (NASDAQ:FDMT) to Neutral - MarketBeat
Is FibroGen Inc (FGEN) a threat to investors? - US Post News
Magnetar Financial LLC Increases Holdings in Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World
Ferovinum Raises £17.5M in Series A Funding - FinSMEs
Femsa stock downgraded as cash-back falls short despite divestments, says JPMorgan - Investing.com Australia
Femsa downgraded to Neutral from Overweight at JPMorgan - TipRanks
Fortune Brands Innovations, Inc. (NYSE:FBIN) is Teca Partners LP's 3rd Largest Position - MarketBeat
Fletcher Building Initiates Trading Halt for Capital Raise - TipRanks
Baupost Group LLC MA Grows Stock Holdings in Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World
4D Molecular Therapeutics Inc [FDMT] Records 200-Day SMA of $22.26 - Knox Daily
First Eagle Investment Management LLC Buys 108,500 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World
Ferovinum secures £17.5m in Series A - FinTech Global
Analyzing Ratios: Fomento Economico Mexicano S.A.B. de C.V. ADR (FMX)’s Financial Story Unveiled - The Dwinnex
Fedbank Financial Services allots 1.32 lakh equity shares under ESOS - Business Standard
A new trading data show 4D Molecular Therapeutics Inc (FDMT) is showing positive returns. - SETE News
Fortress Biotech (FBIO) Prices 3.94M Sharee Offering at $1.65/sh - StreetInsider.com
4D Molecular Therapeutics Inc [FDMT] Revenue clocked in at $21.99 million, down -33.37% YTD: What’s Next? - The DBT News
Ferovinum secures £17.5m for global expansion - The Spirits Business
4D Molecular Therapeutics (NASDAQ:FDMT) Price Target Increased to $39.00 by Analysts at Chardan Capital - Defense World
Ferrum Health Raises $16M in Series A Funding - FinSMEs
Epic Global rebrands as Feenix - Sport for Business
Ferovinum secures £17.5M Series A for wine and spirits platform - Tech.eu
Funding platform Ferovinum raises £17.5m for global expansion, having provided £114m to grow the UK wine and spirits industry - Fintech Alliance
Ferrum Health nabs $16M to get FDA-cleared AI into hospitals - Axios
4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate - Yahoo Finance
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Down 14.4% - MarketBeat
4D Molecular Therapeutics (NASDAQ:FDMT) Given New $39.00 Price Target at Chardan Capital - MarketBeat
4D Molecular Therapeutics' (FDMT) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
London-based Ferovinum a funding and supply chain platform for wine and spirits raises over €20.8 million - EU-Startups
FibroGen Inc (FGEN) can make a big difference with a little luck - SETE News
FibroGen Inc (FGEN) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
FDMT Stock: Exploring 4D Molecular Therapeutics Inc’s Growth - The InvestChronicle
(FEM) Investment Analysis - Stock Traders Daily
Texas Permanent School Fund Corp Has $1.55 Million Position in Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World
Fortrea Holdings Inc. (NASDAQ:FTRE) Shares Bought by Mutual of America Capital Management LLC - MarketBeat
Fabtech Technologies Files for IPO to Fund Expansion - Indiainfoline
Beck Bode LLC Decreases Holdings in Flowserve Co. (NYSE:FLS) - MarketBeat
Stock Radar: Fiem Industries up nearly 30% in 1 month, hits fresh record high in September; buy, sell or h - The Economic Times
4D Molecular Therapeutics (NASDAQ:FDMT) Trading 4.2% Higher - Defense World
FEMSA Stock Declines 20.8% YTD: Is a Recovery on the Horizon? - Yahoo Finance
Femasys Announces Infertility Clinic Customers from Coast to Coast - GlobeNewswire
Fabtech Technologies Files IPO Papers - Indiainfoline
Fletcher Building Reports New Executive Shareholdings - TipRanks
FDMT (4D Molecular Therapeutics Inc) may reap gains as insiders became active recently - Knox Daily
Was anything positive for 4D Molecular Therapeutics Inc (FDMT) stock last session? - US Post News
Fabtech Technologies files DRHP for initial public offering with SEBI - The Economic Times
Upcoming IPO: Mumbai-based Fabtech Technologies files draft papers for IPO with SEBI - MSN
Fabtech Technologies files draft papers with Sebi to raise funds via IPO - Moneycontrol
Investing in FibroGen Inc (FGEN) might be a great opportunity, but the stock is a bit overvalued - US Post News
Mumbai-based Fabtech Technologies Files Draft Papers with SEBI for Upcoming IPO – Here’s What You Need to Know - Share Price India News
16.16%
2.00%
자본화:
|
볼륨(24시간):